BREA, Calif., March 10, 2025 /PRNewswire/ — Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and ...
BREA, Calif., July 9, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today introduces the new DxC 500i Clinical Analyzer*, an integrated clinical chemistry and ...
(RTTNews) - Beckman Coulter Diagnostics, the clinical diagnostics unit of science and technology firm Danaher Corp. (DHR), announced Monday that the new DxC 500i Clinical Analyzer received 510(k) ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical Analyzer. The integrated clinical chemistry and immunoassay analyser claims ...
Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC 500i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results